PM

#46
Philip Morris International Inc Common Stock
177.4 1 USD
-0.68%
Sektor: Konjunkturunabhängige Konsumgüter
Basis: USD
Gewinnwährung: USD
Tagesspanne
177.17
178.09
Jahresspanne
142.11
193.05
Tagesänderung
-0.68%
Monatliche Änderung
+8.55%
6 month change
+12.86%
Jahresänderung
-0.34%
Vorheriger Schlusskurs
178.6 2
Open
177.6 1
Tief
177.1 7
High
178.0 9
Volumen
1 718
Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 276.5 B
  • Employee 85 K
  • Founded N/A
  • CEO Jacek Olczak
  • Website www.pmi.com
  • Headquarter Virginia, United States
  • FIGI BBG000J2XL74
  • Industry Tabakwaren
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
23.29
Preis-Umsatz-Verhältnis
6.21
Dividende je Aktie
1.47
Dividendenrendite in %
6.01

Philip Morris International Inc Common Stock

Philip Morris International Inc. is a tobacco company, with products sold in over 180 countries. Marlboro is PMI’s most recognized brand, but in the last quarter of 2023, Iqos generated the greatest revenue. Philip Morris International is often referred to as one of the companies comprising Big Tobacco. The company ranked No. 121 in the 2025 Fortune 500 list of the largest US corporations by total revenue. The company originated in 1847 in London, but Philip Morris International itself was established in 1987 as an operating company of Philip Morris Companies Inc. In 2003, Philip Morris Companies changed its name to Altria Group. In March 2008, PMI was spun off from Altria and has been an entirely separate entity since then. Philip Morris USA, a subsidiary of PMI's former parent, keeps ownership of the Philip Morris brands for the US market. The company's legal seat is in Stamford, Connecticut. PMI's operational headquarters are in Lausanne, Switzerland. With tobacco being addictive and a leading cause of preventable death globally, the company has faced litigation and regulatory measures from governments and has been the subject of scrutiny by the World Health Organization.

Nachrichten